EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between statin therapy and dementia risk: evidence from All of Us and UK Biobank with coenzyme Q7-related mediation analysis

Zusammenhang zwischen Statintherapie und Demenzrisiko: Evidenz aus All of Us und UK Biobank mit Mediationanalyse zu Coenzym Q7

Da Hoon Lee, Yoon-A Park, Jung Sun Kim, Jeong Yee, Ji Min Han, Hye Sun Gwak

Frontiers in Pharmacology · 29.10.2026 · 17

DOI: 10.3389/fphar.2026.1915633 ↗

Auf einen Blick

In zwei Kohorten war Statintherapie mit einem höheren Demenzrisiko assoziiert. Exploratorisch zeigte sich ein kleiner indirekter Zusammenhang über Coenzym Q7.

Fragestellung

Ist Statintherapie bei Erwachsenen ab 40 Jahren mit einem veränderten Demenzrisiko assoziiert, und spielen LDL-C oder Coenzym Q7 mögliche Vermittlungswege?

Methode

Populationsbasierte retrospektive Kohortenstudie mit All of Us und UK Biobank; Gewichtung mit inverse probability of treatment weighting; Cox-Modelle; explorative Mediationanalyse.

Ergebnisse

All of Us: n = 83.355, davon 31.513 Statin-Anwendende; UK Biobank: n = 173.282, davon 43.976 Statin-Anwendende. Adjustiertes HR für Demenz: 2,22 (95 %-KI 2,02–2,44) und 2,54 (95 %-KI 1,98–3,33).

Einschränkungen

Beobachtungsdesign; widersprüchliche Evidenz in der Literatur.

Schlussfolgerung der Autor:innen

Statintherapie war in beiden Kohorten mit höherem Demenzrisiko assoziiert; der explorative indirekte Zusammenhang über COQ7 ist laut Autor:innen hypothesis-generierend.

Kernaussagen

  • Statintherapie war mit höherem Demenzrisiko assoziiert.
  • Adjustiertes HR: 2,22 und 2,54 in den zwei Kohorten.
  • Indirekter Effekt über Coenzym Q7: 8,2 % der Gesamtassoziation.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.10.2026. Verfasst von Da Hoon Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins are widely prescribed for cardiovascular disease prevention in older adults; however, their association with dementia remains controversial. Given the high prevalence of both statin use and cognitive decline in aging populations, clarifying this relationship has critical implications for geriatric clinical practice and shared decision-making.

Methods

We conducted a population-based retrospective cohort study using the All of Us Research Program (discovery cohort, n = 83,355; 31,513 statin users) and UK Biobank (replication cohort, n = 173,282; 43,976 statin users). Participants were adults aged ≥40 years who self-identified as White, followed from 2006 through 2023 (discovery) and 2017 (replication). Inverse probability of treatment weighting balanced baseline characteristics. Dementia risk was estimated using Cox proportional hazards models. An exploratory mediation analysis examined low-density lipoprotein cholesterol (LDL-C) and coenzyme Q7, a protein involved in CoQ10 biosynthesis, as potential pathways linking statin use and dementia.

Results

Statin use was associated with significantly increased dementia risk in both cohorts (discovery: adjusted HR 2.22, 95% CI 2.02–2.44; replication: adjusted HR 2.54, 95% CI 1.98–3.33). Clear intensity-dependent relationships were observed, with high-intensity statins conferring 14% greater risk than moderate-to-low intensity therapy. In the exploratory mediation analysis, the estimated indirect effect through coenzyme Q7 was statistically significant and accounted for 8.2% of the total association, whereas the indirect effect through LDL-C was not statistically significant.

Conclusion

Statin use was associated with higher dementia risk in both cohorts, and exploratory mediation findings suggested a modest statistical indirect association through COQ7, which should be considered hypothesis-generating. Given the observational design and conflicting evidence in the literature, these findings warrant further investigation before informing clinical decisions about statin therapy.

Schlagwörter

Stichwörter der Autor:innen

COQ7dementiamediation analysispharmacoepidemiologystatins

Autor:innen und Institutionen

  • College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
  • College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea.
  • Human-Centered Artificial Intelligence Research Institute, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
  • School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, D. H., Park, Y. A., Kim, J. S., Yee, J., Han, J. M., & Gwak, H. S. (2026). Association between statin therapy and dementia risk: evidence from All of Us and UK Biobank with coenzyme Q7-related mediation analysis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1915633

Vancouver

Lee DH, Park YA, Kim JS, Yee J, Han JM, Gwak HS. Association between statin therapy and dementia risk: evidence from All of Us and UK Biobank with coenzyme Q7-related mediation analysis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1915633

BibTeX
@article{Lee2026,
  author = {Lee, Da Hoon and Park, Yoon-A and Kim, Jung Sun and Yee, Jeong and Han, Ji Min and Gwak, Hye Sun},
  title = {Association between statin therapy and dementia risk: evidence from All of Us and UK Biobank with coenzyme Q7-related mediation analysis},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1915633}
}
Kostenlos starten →